cDNA cloning and gene mapping of human homologs for Schizosaccharomyces pombe rad17, rad1, and hus1 and cloning of homologs from mouse, Caenorhabditis elegans, and drosophila melanogaster

Genomics

Volumn 54, Issue 3, 1998, Pages 424-436

  Dean, Frank B ^a   Lian, Lubing ^c   O'Donnell, Mike ^a,b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c Myriad Genetic Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; CAENORHABDITIS ELEGANS; CELL CYCLE; CHROMOSOME 5P; CHROMOSOME 5Q; CHROMOSOME 7P; DNA REPAIR; DROSOPHILA MELANOGASTER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; GENETIC CONSERVATION; HUMAN; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHIZOSACCHAROMYCES POMBE; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR GENE;

ARTHROPODA; CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER; EUKARYOTA; MAMMALIA; MELANOGASTER; NEMATODA; SCHIZOSACCHAROMYCES POMBE;

EID: 0032535726     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1998.5587     Document Type: Article

References (88)

1. Al-Khodairy F., Carr A. M. DNA repair mutants defining G2 checkpoint pathways inSchizosaccharomyces pombe. EMBO J. 11:1992;1343-1350.
2. Al-Khodairy F., Fotou E., Sheldrick K. S., Griffiths D. J. F., Lehmann A. R., Carr A. M. Identification and characterization of new elements involved in checkpoint and feedback controls in fission yeast. Mol. Biol. Cell. 5:1994;147-160.
3. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
4. Altschul S. F., Madden T. L., Schäffer A. A., Zhang J., Zhang Z., Miller W., Lipman D. J. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 25:1997;3389-3402.
5. Barbi G., Scheres J. M. J. C., Schindler D., Taalman R. D. F. M., Rodens K., Mehnert K., Mueller M., Seyschab H. Chromosome instability and X-ray hypersensitivity in a microcephalic and growth-retarded child. Am. J. Med. Genet. 40:1991;44-50.
6. Bentley N. J., Carr A. M. DNA structure-dependent checkpoints in model systems. Biol. Chem. 378:1997;1267-1274.
7. Bentley N. J., Holtzman D. A., Flaggs G., Keegan S., DeMaggio A., Ford J. C., Hoekstra M., Carr A. M. TheSchizosaccharomyces pombe rad3. EMBO J. 15:1996;6641-6651.
8. Berger C. S., Sandberg A. A., Todd I. A., Pennington R. D., Haddad F. S., Hecht B. K., Hecht F. Chromosomes in kidney, ureter, and bladder cancer. Cancer Genet. Cytogenet. 23:1986;1-24.
9. Bohm M., Kirch H., Otto T., Rubben H., Wieland I. Deletion analysis at the DEL-27, APC and MTS1 loci in bladder cancer: LOH at the DEL-27 locus on 5p13-12 is a prognostic marker of tumour progression. Int. J. Cancer. 74:1997;291-295.
10. scsp. Curr. Opin. Genet. Dev. 7:1997;93-98.
11. Carr A. M., Hoekstra M. F. The cellular responses to DNA damage. Trends Cell Biol. 5:1995;32-40.
12. Cimprich K. A., Shin T. B., Keith C. T., Schreiber S. L. cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proc. Natl. Acad. Sci. USA. 93:1996;2850-2855.
13. Collins K., Jacks T., Pavletich N. P. The cell cycle and cancer. Proc. Natl. Acad. Sci. USA. 94:1997;2776-2778.
14. Conley M. E., Spinner N. B., Emanuel B. S., Nowell P. C., Nichols W. W. Chromosomal breakage syndrome with profound immunodeficiency. Blood. 67:1986;1251-1256.
15. Cox D. R., Burmeister M., Price E. R., Kim S., Myers R. M. Radiation hybrid mapping: A somatic cell genetic method for constructing high-resolution maps of mammalian chromosomes. Science. 250:1990;245-250.
16. Dewald G. W., Noonan K. J., Spurbeck J. L., Johnson D. D. T-lymphocytes with 7;14 translocations: Frequency of occurrence, breakpoints, and clinical and biological significance. Am. J. Hum. Genet. 38:1986;520-532.
17. Dyer M. J. S., Nacheva E., Fischer P., Heward J. M., Labastide W., Karpas A. A new human T-cell lymphoma cell line (Karpas 384) of the T-cell receptor gamma/delta lineage with translocation t(7:14)(p13;q11.2). Leukemia. 7:1993;1047-1053.
18. Enoch T., Nurse P. Mutation of fission yeast cell cycle control genes abolishes dependence of mitosis on DNA replication. Cell. 60:1990;665-673.
19. Enoch T., Carr A. M., Nurse P. Fission yeast genes involved in coupling mitosis to completion of DNA replication. Genes Dev. 6:1992;2035-2046.
20. Enoch T., Norbury C. Cellular responses to DNA damage: Cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. Trends Biochem. Sci. 20:1995;426-430.
21. Fairman J., Wang R. Y., Liang H., Zhao L., Saltman D., Liang J. C., Nagarajan L. Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia: Evidence for a novel critical locus. Blood. 88:1996;2259-2266.
22. Gogineni S. K., da Costa M., Verma M. S. A new translocation, t(5;21)(q13;q22) in acute myelogenous leukemia. Cancer Genet. Cytogenet. 88:1996;167-169.
23. Goguel A. F., Fouquet F., Duverger A., Arvelo F., Jacrot M., Poupon M. F., Bernheim A. Evolution of chromosomal alterations and biologic features in two small cell lung carcinoma cell lines established from one patient during the course of the disease. Cancer Genet. Cytogenet. 80:1995;47-54.
24. Green A. J., Yates J. R. W., Taylor A. M. R., Biggs P., McGuire G. M., McConville C. M., Billing C. J., Barnes N. D. Severe microcephaly with normal intellectual development: The Nijmegem breakage syndrome. Arch. Dis. Child. 73:1995;431-434.
25. Griffiths D. J. F., Barbet N. C., McReady S., Lehmann A. R., Carr A. M. Fission yeastrad17:RAD24. EMBO J. 14:1995;5812-5823.
26. Gyapay G., Schmitt K., Fizames C., Jones H., Vega-Czarny N., Spillett D., Muselet D., Prud'Homme J. F., Dib C., Auffray C., Morissette J., Weissenbach J., Goodfellow P. N. A radiation hybrid map of the human genome. Hum. Mol. Genet. 5:1996;339-346.
27. Hartwell L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell. 71:1992;543-546.
28. Hartwell L., Kastan M. B. Cell cycle control and cancer. Science. 266:1994;1821-1828.
29. Hartwell L., Weinert T. A. Checkpoints: Controls that ensure the order of cell cycle events. Science. 246:1989;629-634.
30. Hecht F., Hecht B. K. Chromosome changes connect immunodeficiency and cancer in ataxia-telangiectasia. Am. J. Pediatr. Hematol. Oncol. 9:1987;185-188.
31. Hecht F., Hecht B. K., Kirsch I. R. Fragile sites limited to lymphocytes: Molecular recombination and malignancy. Cancer Genet. Cytogenet. 26:1987;95-104.
32. Heng H. H. Q., Squire J., Tsui L. C. High resolution mapping of mammalian genes by in situ hybridization to free chromatin. Proc. Natl. Acad. Sci. USA. 89:1992;9509-9513.
33. Heng H. H. Q., Tsui L. C. Modes of DAPI banding and simultaneous in situ hybridization. Chromosoma. 102:1993;325-332.
34. Holden D. W., Spanos A., Banks G. R. Nucleotide sequence of theREC1Ustilago maydis. Nucleic Acids Res. 17:1989;10489.
35. Holliday R., Halliwell R. E., Evans M. W., Rowell V. Genetic characterization ofrecUstilago maydis. Genet. Res. 27:1976;413-453.
36. Jackson S. P. The recognition of DNA damage. Curr. Opin. Genet. Dev. 6:1996;19-25.
37. +Schizosaccharomyces pombe. Proc. Natl. Acad. Sci. USA. 89:1992;4952-4956.
38. Jonveaux P., Le Coniat M., Derre J., Vecchione D., Berger R. Deletion of (7p13p14) in non-Hodgkin's lymphoma. Cancer Genet. Cytogenet. 50:1990;53-56.
39. +. Mol. Biol. Cell. 6:1995;1793-1805.
40. Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
41. Kelman Z., O'Donnell M. DNA polymerase III holoenzyme: Structure and function of a chromosomal replicating machine. Annu. Rev. Biochem. 64:1995;171-200.
42. Keppen L. D., Gollin S. M., Edwards D., Sawyer J., Wilson W., Overhauser J. Clinical phenotype and molecular analysis of a three-generation family with an interstitial deletion of the short arm of chromosome 5. Am. J. Med. Genet. 44:1992;356-360.
43. Kinzler K. W., Vogelstein B. Gatekeepers and caretakers. Nature. 386:1997;761-762.
44. Koonin E. V. A common set of conserved motifs in a vast variety of putative nucleic acid-dependent ATPases including MCM proteins involved in the initiation of eukaryotic DNA replication. Nucleic Acids Res. 21:1993;2541-2547.
45. Koonin E. V. A conserved ancient domain joins the growing superfamily of 3′-5′ exonucleases. Curr. Biol. 7:1997;R604-606.
46. +. Mol. Gen. Genet. 254:1997;389-399.
47. Kostrub C. F., Knudsen K., Subramani S., Enoch T. Hus1p, a conserved fission yeast checkpoint protein, interacts with Rad1p and is phosphorylated in response to DNA damage. EMBO J. 7:1998;2055-2066.
48. Kuerbitz S. J., Plunkett B. S., Walsh W. V., Kastan M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA. 89:1992;7491-7495.
49. Lehmann A. R., Carr A. M. The ataxia-telangiectasia gene: A link between checkpoint controls, neurodegeneration, and cancer. Trends Genet. 11:1995;375-377.
50. +. Proc. Natl. Acad. Sci. USA. 93:1996;13890-13895.
51. Long K. E., Sunnerhagen P., Subramani S. TheSchizosaccharomyces pombe rad1Ustilago maydis REC1. Gene. 148:1994;155-159.
52. Longhese M. P., Paciotti V., Fraschini R., Zaccarini R., Plevani P., Lucchini G. The novel DNA damage checkpoint protein Ddc1p is phosphorylated periodically during the cell cycle and in response to DNA damage in budding yeast. EMBO J. 16:1997;5216-5226.
53. Lydall D., Weinert T. Yeast checkpoint genes in DNA damage processing: Implications for repair and arrest. Science. 270:1995;1488-1491.
54. Lydall D., Weinert T. From DNA damage to cell cycle arrest and suicide: A budding yeast perspective. Curr. Opin. Genet. Dev. 6:1996;4-11.
55. Lydall D., Weinert T. G2/M checkpoint genes ofSaccharomyces cerevisiae: Mol. Gen. Genet. 256:1997;638-651.
56. McFarlane R. J., Carr A. M., Price C. Characterization of theSchizosaccharomyces pombe rad4/cut5. Mol. Gen. Genet. 255:1997;332-340.
57. Miura I., Graziano S. L., Cheng J. Q., Doyle L. A., Testa J. R. Chromosome alterations in human small cell lung cancer: Frequent involvement of 5q. Cancer Res. 52:1992;1322-1328.
58. Morgan R., Walter T. A., Decker H. J., Hecht F., Sandberg A. A. Inversion of chromosome 5 long arm in region of cell growth gene cluster in hematologic disorders. Cancer Genet. Cytogenet. 32:1988;267-275.
59. Murray J. M., Carr A. M., Lehmann A. R., Watts F. Z. Cloning and characterization of therad9Schizosaccharomyces pombe. Nucleic Acids Res. 19:1991;3525-3531.
60. Nasim A., Smith B. P. Genetic control of radiation sensitivity inSchizosaccharomyces pombe. Genetics. 79:1975;573-582.
61. Onel K., Thelen M. P., Ferguson D. O., Bennett R. L., Holloman W. K. Mutation avoidance and DNA repair proficiency inUstilago maydisREC1. Mol. Cell. Biol. 15:1995;5329-5338.
62. Onel K., Koff A., Bennett R. L., Unrau P., Holloman W. K. TheREC1Ustilago maydis, Genetics. 143:1996;165-174.
63. Ordnal C., Mandahl N., Rydholm A., Willen H., Brosjo O., Mitelman F. Chromosome aberrations and cytogenetic intratumor heterogeneity in chondrosarcomas. J. Cancer Res. Clin. Oncol. 120:1993;51-56.
64. +. J. Biol. Chem. 273:1998a;18332-18339.
65. +. J. Biol. Chem. 273:1998b;18340-18346.
66. Pejovic T. Genetic changes in ovarian cancer. Ann. Med. 27:1995;73-78.
67. Renedo M., Robledo M., Arranz E., Infantes F., Roman A., Garcia-Yebenes J., Benitez J. Cytogenetic and molecular studies of siblings with ataxia telangiectasia followed for 7 years. Cancer Genet. Cytogenet. 95:1997;178-182.
68. Rowley R., Subramani S., Young P. G. Checkpoint controls inSchizosaccharomyces pombe: rad1. EMBO J. 11:1992;1335-1342.
69. Russell P., Nurse P. Schizosaccharomyces pombeSaccharomyces cerevisiae: Cell. 45:1986;781-782.
70. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D. A., Smith S., Uziel T., Sfez, Ashkenazi M., Pecker I., Frydman M., Harnik R., Patanjali S. R., Simmons A., Clines G. A., Sartiel A., Gatti R. R., Chessa L., Sanal O., Lavin M. F., Jaspers N. G. J., Taylor A. M. R., Arlett C. F., Miki T., Weissman S. M., Lovett M., Collins F. S., Shiloh Y. A singleataxia telangiectasia. Science. 268:1995;1749-1753.
71. Scheres J. M., Hustinx T. W., Trent J. M. Possible involvement of unstable sites on chromosomes 7 and 14 in human cancer. Cancer Genet. Cytogenet. 19:1986;151-158.
72. Shanske A. L., Kalman A., Grunwald H. A myeloproliferative disorder with eosinophila associated with a unique translocation (3;5). Br. J. Haematol. 95:1996;524-526.
73. Sheldrick K. S., Carr A. M. Feedback controls and G2 checkpoints: Fission yeast as a model system. BioEssays. 15:1993;775-782.
74. Siede W., Nusspaumer G., Portillo V., Rodriguez R., Friedberg E. C. Cloning and characterization ofRAD17,Saccharomyces cerevisiae. Nucleic Acids Res. 24:1996;1669-1675.
75. Stewart E., Enoch T. S-phase and DNA-damage checkpoints: A tale of two yeasts. Curr. Opin. Cell Biol. 8:1996;781-787.
76. Sunnerhagen P., Seaton B. L., Nasim A., Subramani S. Cloning and analysis of a gene involved in DNA repair and recombination, therad1Schizosaccharomyces pombe. Mol. Cell. Biol. 10:1990;3750-3760.
77. Taalman R. D. F. M., Hustinx T. W. J., Weemaes C. M. R., Seemanova E., Schmidt A., Passarge E., Scheres M. J. C. Further delineation of the Nijmegen breakage syndrome. Am. J. Med. Genet. 32:1989;425-431.
78. Tarkkanen M., Kaipainen A., Karaharju E., Bohling T., Szymanska J., Helio H., Kivioja A., Elomaa I., Knuutila S. Cytogenetic study of 249 consecutive patients examined for a bone tumor. Cancer Genet. Cytogenet. 68:1993;1-21.
79. Tavassoli M., Steingrimsdottir H., Pierce E., Jiang X., Alagoz M., Farzaneh F., Campbell I. G. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied byTP53. Br. J. Cancer. 74:1996;115-119.
80. Thelen M. P., Onel K., Holloman W. K. TheREC1Ustilago maydis. J. Biol. Chem. 269:1994;747-754.
81. Tsukuda T., Bauchwitz R., Holloman W. K. Isolation of theREC1Ustilago maydis. Gene. 85:1989;335-341.
82. Uckun F. M., Kersey J. H., Gajl-Peczalska K. J., Heerema N. A., Provisor A. J., Haag D., Gilchrist G., Song C. W., Arthur D. C., Roloff J., Lampkin B., Greenwood M., Dewald G., Vallera D. A. Heterogeneity of cultured leukemic lymphoid progenitor cells from B cell precursor acute lymphoblastic leukemia (ALL) patients. J. Clin. Invest. 80:1987;639-646.
83. Uckun F. M., Gajl-Peczalska K. J., Provisor A. J., Heerema N. A. Immunophenotype-karyotype associations in human acute lymphoblastic leukemia. Blood. 73:1989;271-280.
84. Weinert T. A., Hartwell L. H. Characterization ofRAD9Saccharomyces cerevisiae. Mol. Cell. Biol. 10:1990;6554-6564.
85. Weinert T. A., Kiser G. L., Hartwell L. H. Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair. Genes Dev. 8:1994;652-665.
86. Wieland I., Bohm M., Arden K. C., Ammermuller T., Bogatz S., Viars C. S., Rajewsky M. F. Allelic deletion mapping on chromosome 5 in human carcinomas. Oncogene. 12:1996;97-102.
87. Willson J., Wilson S., Warr N., Watts F. Z. Isolation and characterization of theSchizosaccharomyces pombe rhp9. Nucleic Acids Res. 25:1997;2138-2146.
88. Yeatman T. J., Cher M. L., Mao W., Wloch M., Tedesco T. Identification of genetic alterations associated with the process of human experimental colon cancer liver metastasis in the nude mouse. Clin. Exp. Metastasis. 14:1996;246-252.